Delivering a compact CRISPR, "psCas12f," which can be turned on and off with light, via a single AAV, and performing genome editing "only where targeted" using focused ultrasound via light-emitting pa ...
Mammoth Biosciences researchers have developed NanoCas, an ultracompact CRISPR nuclease, demonstrating its ability to perform gene editing in non-liver tissues, including skeletal muscle, using a ...
Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study and alter neurophysiological processes. These include CRISPR (Clustered ...
Spread the loveImagine looking in the mirror and seeing a younger version of yourself, not just cosmetically, but at a ...
A team of scientists has made an important breakthrough in the fight against RNA viruses that cause human diseases and pandemics. A team of scientists from A*STAR's Genome Institute of Singapore (GIS) ...
Within the field of cell therapy, there is a consistent need from researchers to manufacture cGMP virus to support the advancements of these critical therapies. While many AAV manufacturing platforms ...
Dublin, April 16, 2026 (GLOBE NEWSWIRE)-- The "Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2026-2034" has been added to ...
Gene therapies that are based on adeno-associated virus (AAV) vectors have demonstrated immense potential to treat and even cure previously intractable diseases, but unfortunately the costs are ...
ERS Genomics Limited ('ERS Genomics'), the CRISPR licensing company, today announced that it has signed a non-exclusive ...
Human cells hold about two meters (6.6 feet) of DNA, folded and compacted to fit inside a nucleus. That packing is essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results